Michelle Mellion
Corporate Officer/Principal chez PEPGEN INC.
Fortune : - $ au 30/04/2024
Profil
Michelle L.
Mellion is a professional with experience in the pharmaceutical industry.
She is currently the Senior Vice President-Clinical Development at PepGen Inc. Prior to this, she worked as an Executive Medical Director at Fulcrum Therapeutics, Inc. from 2018 to 2022.
She also worked as a Medical Director at Vertex Pharmaceuticals, Inc. from 2016 to 2018 and as an Associate Medical Director at Biogen, Inc. from 2015 to 2016.
Dr. Mellion holds a doctorate degree from Wake Forest University and an undergraduate degree from Colgate University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PEPGEN INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Michelle Mellion
| Sociétés | Poste | Début |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01/04/2022 |
Anciens postes connus de Michelle Mellion
| Sociétés | Poste | Fin |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur Technique/Scientifique/R&D | 01/08/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2016 |
Formation de Michelle Mellion
| Wake Forest University | Doctorate Degree |
| Colgate University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PEPGEN INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
